Desmethoxyfallypride

From WikiMD's WELLNESSPEDIA

Desmethoxyfallypride_18F.svg

Chemical compound

Desmethoxyfallypride































Desmethoxyfallypride is a chemical compound that is used in medical research and pharmacology. It is a derivative of fallypride, which is a dopamine D2/D3 receptor antagonist. Desmethoxyfallypride is primarily utilized in positron emission tomography (PET) imaging to study the dopamine receptor system in the brain.

Chemical Properties[edit]

Desmethoxyfallypride has a chemical structure similar to that of fallypride, but it lacks a methoxy group. This slight modification can affect its binding affinity and selectivity for dopamine receptors. The chemical formula of desmethoxyfallypride is C18H25Cl2N3O2.

Applications in Research[edit]

Desmethoxyfallypride is used in neuroscience research to investigate the role of dopamine receptors in various neurological disorders such as schizophrenia, Parkinson's disease, and addiction. By using PET imaging, researchers can visualize and quantify the distribution of dopamine receptors in the brain, which can provide insights into the pathophysiology of these disorders.

Pharmacology[edit]

As a dopamine D2/D3 receptor antagonist, desmethoxyfallypride binds to these receptors and inhibits their activity. This property makes it useful in studying the dopaminergic system, which is implicated in many psychiatric and neurological conditions. The pharmacokinetics of desmethoxyfallypride, including its absorption, distribution, metabolism, and excretion, are important for understanding its behavior in the body and optimizing its use in research.

Safety and Handling[edit]

As with many research chemicals, proper safety protocols should be followed when handling desmethoxyfallypride. This includes using appropriate personal protective equipment (PPE) and working in a controlled environment to prevent exposure and contamination.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.